Squamous Cell Carcinoma Plasma

Squamous Cell Carcinoma Plasma is collected from IRB-consented donors diagnosed with clinically confirmed Squamous Cell Carcinoma (SCC). These plasma samples are ideal for quantifying tumor-derived circulating factors and immune biomarkers. Plasma from SCC donors enables tracking of disease progression, therapeutic impact, and identification of prognostic indicators.

Product Features

• Cryopreserved, clinically verified SCC Plasma samples
• Cryopreserved to ensure stability and long-term storage
• Research Use Only (RUO)

Donor Metadata

• Clinically confirmed SCC diagnosis
• Donor demographics: age, sex assigned at birth, ethnicity
• Medical and treatment history available when applicable

Applications

• Quantifying tumor-derived circulating factors and immune biomarkers
• Biomarker discovery and validation
• Transcriptomic, proteomic, or functional studies
• Custom assay development and disease modeling

Compliance and Quality

• IRB-approved collection and electronic informed consent
• HIPAA-compliant donor data handling

Ordering and Customization

Squamous Cell Carcinoma Plasma is available in standard and custom volumes. Contact [email protected] for international requests or documentation needs.